acrolein has been researched along with Bone Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, PN; Chu, SC; Hsieh, YS; Hsu, LS; Lai, YA; Lin, CY | 1 |
| Li, J; Li, M; Shi, X; Wang, F; Zhang, Q; Zhang, Y | 1 |
| Chen, J; Huang, H; Huang, Y; Luo, J; Luo, X; Tan, T; Wang, N; Wang, Y; Yang, C; Yang, S; Zhang, L | 1 |
3 other study(ies) available for acrolein and Bone Cancer
| Article | Year |
|---|---|
Cinnamaldehyde decreases the invasion and u-PA expression of osteosarcoma by down-regulating the FAK signalling pathway.
Topics: Acrolein; Animals; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Focal Adhesion Protein-Tyrosine Kinases; Humans; Mice; Osteosarcoma; Signal Transduction; Urokinase-Type Plasminogen Activator | 2022 |
Activatable Semiconducting Polymer Nanoinducers Amplify Oxidative Damage via Sono-Ferroptosis for Synergistic Therapy of Bone Metastasis.
Topics: Acrolein; Bone Neoplasms; Cell Line, Tumor; Ferroptosis; Humans; Hydrogen Peroxide; Nanoparticles; Neoplasms; Oxidative Stress; Polymers | 2023 |
Cinnamaldehyde Inhibits the Function of Osteosarcoma by Suppressing the Wnt/β-Catenin and PI3K/Akt Signaling Pathways.
Topics: Acrolein; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; beta Catenin; Bone Neoplasms; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Osteosarcoma; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Structure-Activity Relationship; Tumor Cells, Cultured | 2020 |